Patents Assigned to Osaka Pharmaceutical Co., Ltd.
  • Publication number: 20210251220
    Abstract: Problem to be Solved An object of the present invention is to provide an eliminator that exterminates lice by blocking the lice from the outside, for example, by sealing the spiracle of the louse, that can be used on humans, animals, clothes, and the like, and that is easy to adhere to and spread out over the outer skin of lice without being repelled by the outer skin when brought into contact with the lice. Solution The problem can be solved by a lice eliminator or the like which is characterized in that a louse precipitation rate which is a proportion in percentage of the lice precipitating completely into the lice eliminator with respect to the lice dropped onto the lice eliminator when multiple lice have been dropped is 50 to 100%.
    Type: Application
    Filed: March 28, 2019
    Publication date: August 19, 2021
    Applicants: Osaka Pharmaceutical Co., Ltd., Dainihon Jochugiku Co., Ltd.
    Inventor: Naoko IKEDA
  • Patent number: 7582732
    Abstract: The invention provides a brain-specific gene useful in treating Alzheimer's disease, for instance, which comprises a nucleotide sequence cording for the amino acid sequence shown in SEQ ID NO:1 and fragments thereof; an expression vector comprising the gene; a host cell comprising the expression vector; an expression product of the gene; an antibody against the product; a therapeutic and prophylactic composition for neurodegenerative disease; and the like.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: September 1, 2009
    Assignee: Osaka Pharmaceutical Co., Ltd.
    Inventors: Masato Horie, Keiichi Okutomi, Yoshihiro Taniguchi, Mikio Suzuki, Yutaka Ohbuchi